Silencing of HOXB9 suppresses cellular proliferation, angiogenesis, migration and invasion of prostate cancer cells.

In conclusion, our findings revealed that HOXB9 promotes prostate cancer progression and might be a novel and effective therapeutic target for human prostate cancer.
PMID: 32098919 [PubMed - in process]

Source: Journal of Biosciences - February 28, 2020 Category: Biomedical Science Authors: Xu H, Wu S, Shen X, Wu D, Qin Z, Wang H, Chen X, Sun X Tags: J Biosci Source Type: research